Company: IMNN
Filing Date: 2025-05-12
Form Type: 10-Q
Source: 0001641172-25-009572
Chunk: 127

Company: Imunon, Inc.
Filing Date: 2025-05-12
Form: 10-Q
Item: Part I, Item 8
Chunk 127
---
 well conceived
and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Because of the
inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances
of fraud, if any, within the company have been detected. These inherent limitations include the realities that judgments in decision-making
can be faulty, and that breakdowns can occur because of simple errors or mistakes. Additionally, controls can be circumvented by the
individual acts of some persons, by collusion of two or more people or by management override of the control. The design of any system
of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that
any design will succeed in achieving its stated goals under all potential future conditions. Over time, controls may become inadequate
because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate. Because of the inherent
limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

PART
II: OTHER INFORMATION

Item
1. Legal Proceedings 

We
are not currently a party to any material legal proceedings.

Item
1A. Risk Factors

There
have been no material changes to our risk factors from those disclosed under “Risk Factors” in Part I, Item 1A of our 2024
Annual Report on Form 10-K. The risks and uncertainties described in our 2024 Annual Report on Form 10-K are not the only ones we face.
Additional risks and uncertainties not presently known to us or that we currently deem immaterial may also materially adversely affect
our business, financial condition, or results of operations.

Item
2. Unregistered Sales of Equity Securities and Use of Proceeds.

None.

Item
3. Defaults Upon Senior Securities.

None.

Item
4. Mine Safety Disclosures.

Not
applicable.

Item
5. Other Information.

During
the quarter ended March 31, 2025, no directors or executive officers entered into, modified or terminated, contracts, instructions or
written plans for the sale or purchase of the Company’s securities that were intended to satisfy the affirmative defense conditions
of Rule 10b5-1.

27

Item
6. Exhibits. 

    10.1++
     
    Offer Letter of Employment, dated February 1, 2025, between Imunon, Inc. and